UK markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
906.54-0.78 (-0.09%)
At close: 04:00PM EDT
906.54 0.00 (0.00%)
After hours: 04:43PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts21202625
Avg. Estimate10.0410.934547.57
Low estimate8.569.2736.4841.73
High estimate11.6212.652.656.4
Year ago EPS10.0910.2443.7945
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts20182625
Avg. Estimate3.21B3.39B13.93B14.96B
Low estimate3B3.15B13.04B13.69B
High estimate3.51B3.65B14.75B17.18B
Year ago sales3BN/A13.12B13.93B
Sales growth (year/est)6.90%N/A6.20%7.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS9.569.8410.7210.73
Actual EPS10.0910.2411.5911.86
Difference0.530.40.871.13
Surprise %5.50%4.10%8.10%10.50%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate10.0410.934547.57
7 days ago10.0711.0245.1347.43
30 days ago9.9610.9544.7847.27
60 days ago10.0211.0644.8547.26
90 days ago10.411.2244.6247.9
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/A1
Up last 30 days5576
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/A2N/A
Growth estimatesREGNIndustrySector(s)S&P 500
Current qtr.-0.50%N/AN/AN/A
Next qtr.6.70%N/AN/AN/A
Current year2.80%N/AN/AN/A
Next year5.70%N/AN/AN/A
Next 5 years (per annum)7.36%N/AN/AN/A
Past 5 years (per annum)17.45%N/AN/AN/A